Assessing Risk Factors in Patients with Chronic Heart Failure and Metabolic Syndrome

2026

Полный текст Открытый доступ: Hybrid Метаданные (CSL-JSON)
DOI 10.4103/wkmj.wkmj_50_26
Достоверность данных 70 средняя
Как считается эта оценка

Складывается из проверяемых признаков самой записи: есть ли у статьи DOI, сколько независимых источников подтвердили её данные, заполнены ли обязательные поля и насколько свежо последнее подтверждение. Снижают оценку расхождения между источниками и отсутствие идентификатора. Значение от 80 означает, что запись опубликована без дополнительной проверки; от 60 до 79 — что она опубликована с пониженной достоверностью и ручная проверка желательна. Запись, выверенную редактором вручную, пересчёт не опускает ниже 90. Это оценка наших данных о статье, а не оценка самой статьи.

Аннотация

A BSTRACT Background: Chronic heart failure (CHF) is a multifaceted clinical condition that affects over huge number of individuals globally. Precise diagnosis and appropriate management are essential to prevent repeated hospital admissions, lower rates of illness and death, and enhance overall patient outcomes. Aims and Objectives: CHF is a significant medical problem, characterized by high morbidity and mortality, particularly when combined with metabolic syndrome (MS). We compared risk factors associated with the progression to HF in patients with or without with and without metabolic syndrome. Materials and Methods: During a follow-up of 3 months, 35 patients with prior MS and 35 patients without prior MS experienced CHF. Results: In our study, high blood pressure was found to be significantly associated with metabolic syndrome ( P = 0.0062). Patients with chronic heart failure and metabolic syndrome were more likely to have arterial hypertension compared to those without metabolic syndrome. Coronary artery disease was more strongly associated with CHF onset in patients with prior MS (all P for interactions <0.05). The triglyceride level in the MS group was significantly higher only in patients with prior MS (all P for interactions <0.05). Conclusion: The importance of clinical risk factors associated with CHF is dependent on whether the patient has had a prior MS. Coronary heart disease and hypertension are associated with CHF only in the presence of metabolic syndrome. Patients may benefit from early detection and correction of MS risk factors in CHF.